SCHEMBL6785034

SCHEMBL6785034

CCCCOc1ccc(N(CCC2(O)CCN(CCc3ccc(F)cc3)CC2)C(C)=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 2/20 0.44
MMP13 P45452 2/20 0.44
MMP1 P03956 1/20 0.44
THRB P10828 1/20 0.42
HTR2A P28223 3/20 0.41
OPRM1 P35372 3/20 0.41
HRH1 P35367 3/20 0.41
DRD2 P14416 2/20 0.41
DRD1 P21728 2/20 0.41
DRD5 P21918 2/20 0.41
HTR7 P34969 2/20 0.41
DRD3 P35462 2/20 0.41
HTR1A P08908 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR2B P41595 1/20 0.41
ADAM17 P78536 1/20 0.40
HRH2 P25021 2/20 0.39
FAAH O00519 1/20 0.39
CACNA1F O60840 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6780987 0.99 MMP9 (0.43) MMP9MMP13MMP1THRBHTR2A
SCHEMBL6791086 0.87 HTR2A (0.43) MMP9MMP13MMP1THRBHTR2A
Hydrochloric Acid SCHEMBL6785753 0.86 HTR2A (0.42) MMP9MMP13MMP1THRBHTR2A
SCHEMBL6783771 0.81 ACHE (0.52) MMP9MMP13MMP1ADAM17FAAH
Hydrochloric Acid SCHEMBL6784374 0.81 ACHE (0.52) MMP9MMP13MMP1ADAM17FAAH
SCHEMBL6785650 0.79 CACNA1B (0.48) MMP9MMP13MMP1THRBHTR2A
Hydrochloric Acid SCHEMBL6783344 0.79 CACNA1B (0.48) MMP9MMP13MMP1THRBHTR2A
SCHEMBL6783426 0.79 SIGMAR1 (0.46) MMP9MMP13MMP1THRBOPRM1
SCHEMBL6785641 0.79 MMP9 (0.44) MMP9MMP13MMP1THRBHTR2A
Hydrochloric Acid SCHEMBL6782777 0.78 SIGMAR1 (0.45) MMP9MMP13MMP1THRBOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710060-B2 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2004-03-23 US disclosed
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-12-12 US disclosed
EP-1182192-A1 4-HYDROXYPIPERIDINE DERIVATIVES HAVING ANTIARRHYTHMIC EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity SCN5A, RYR2, SCN1B MMP9 1184/4885MMP13 3448/4885MMP1 1180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.